Chih-Hua Tseng Selected Research

3',4',7-trihydroxyisoflavone

1/2018	Preparation, characterizations and anti-pollutant activity of 7,3',4'-trihydroxyisoflavone nanoparticles in particulate matter-induced HaCaT keratinocytes.
1/2016	Design of acid-responsive polymeric nanoparticles for 7,3',4'-trihydroxyisoflavone topical administration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chih-Hua Tseng Research Topics

Disease

23	Neoplasms (Cancer) 01/2022 - 03/2008
8	Breast Neoplasms (Breast Cancer) 08/2016 - 02/2010
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2019 - 03/2008
4	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 03/2008
4	Infections 01/2020 - 01/2017
3	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2022 - 10/2018
3	Inflammation (Inflammations) 09/2021 - 01/2018
2	Hyperplasia 04/2022 - 08/2020
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2019
2	Liver Neoplasms (Liver Cancer) 01/2021 - 01/2017
2	Skin Neoplasms (Skin Cancer) 05/2019 - 01/2016
2	Diarrhea 01/2019 - 11/2017
2	Lung Neoplasms (Lung Cancer) 12/2015 - 07/2011
2	Prostatic Neoplasms (Prostate Cancer) 01/2015 - 03/2008
2	Neoplasm Metastasis (Metastasis) 01/2015 - 02/2013
2	Polyploidy 04/2013 - 03/2008
2	Sepsis (Septicemia) 05/2012 - 09/2009
2	Squamous Cell Carcinoma of Head and Neck 06/2010 - 03/2008
2	Carcinoma (Carcinomatosis) 11/2009 - 03/2008
1	Carcinogenesis 01/2022
1	Dysbiosis 01/2022
1	Bacteriuria 05/2020
1	Malaria 05/2020
1	Atopic Dermatitis (Atopic Eczema) 01/2018
1	Drug-Related Side Effects and Adverse Reactions 11/2017
1	Tuberculosis (Tuberculoses) 06/2017
1	Abscess 01/2017
1	Glioma (Gliomas) 08/2016
1	Retinoblastoma (Glioblastoma, Retinal) 04/2016
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2014

Drug/Important Bio-Agent (IBA)

16	quinolineIBA 05/2020 - 03/2008
8	N-formyl-13-dihydrocarminomycin (NFD)IBA 02/2019 - 01/2010
5	Biological ProductsIBA 05/2020 - 01/2013
5	Pharmaceutical PreparationsIBA 01/2020 - 01/2015
5	furanIBA 02/2014 - 01/2010
3	GlucuronidaseIBA 01/2022 - 11/2017
3	pterostilbeneIBA 09/2021 - 01/2017
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2019 - 12/2015
3	DNA (Deoxyribonucleic Acid)IBA 04/2013 - 03/2008
2	Imiquimod (Aldara)FDA LinkGeneric 04/2022 - 10/2018
2	CarcinogensIBA 01/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 09/2021 - 08/2010
2	Particulate MatterIBA 09/2021 - 01/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2021 - 04/2016
2	Thalidomide (Thalomid)FDA Link 08/2020 - 10/2018
2	Caspase 3 (Caspase-3)IBA 05/2019 - 08/2010
2	trioctyl phosphine oxide (TOPO)IBA 02/2019 - 08/2010
2	AntioxidantsIBA 01/2018 - 01/2016
2	3',4',7-trihydroxyisoflavoneIBA 01/2018 - 01/2016
2	daidzeinIBA 01/2018 - 01/2016
2	CamptothecinIBA 08/2016 - 08/2010
2	9- methoxy- 6- (piperazin- 1- yl)- 11H- indeno(1,2- c)quinoline- 11- one O-3-(dimethylamino)propyl oximeIBA 08/2016 - 04/2013
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 08/2016 - 04/2013
2	OximesIBA 11/2013 - 08/2010
2	ErbB Receptors (EGF Receptor)IBA 02/2013 - 06/2010
1	IsoflavonesIBA 04/2022
1	Air Pollutants (Pollutants, Air)IBA 09/2021
1	Indicators and Reagents (Reagents)IBA 09/2021
1	Sarcosine (Methylglycine)IBA 01/2021
1	TransferasesIBA 01/2021
1	CytokinesIBA 08/2020
1	benzyl chlorideIBA 08/2020
1	CurcuminIBA 07/2020
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 02/2019
1	PhytochemicalsIBA 02/2019
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 10/2018
1	Interleukin-8 (Interleukin 8)IBA 10/2018
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2018
1	EnzymesIBA 11/2017
1	GlucuronidesIBA 11/2017
1	Isoniazid (Ftivazide)FDA LinkGeneric 06/2017
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2017
1	QuinolonesIBA 04/2016
1	Melanins (Melanin)IBA 01/2016
1	Topotecan (Hycamtin)FDA LinkGeneric 12/2015
1	Antineoplastic Agents (Antineoplastics)IBA 06/2015
1	2-furanylvinylquinolineIBA 01/2015
1	Antimitotic AgentsIBA 01/2015
1	1- (4- (furo(2,3- b)quinolin- 4- ylamino)phenyl)ethanoneIBA 01/2015
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 09/2014
1	furano-1,2-naphthoquinoneIBA 05/2014
1	Bromodeoxyuridine (BrdU)IBA 04/2013
1	beta-lapachoneIBA 01/2013
1	fosbretabulin (combretastatin A4)IBA 11/2012
1	Prostaglandins EIBA 05/2012
1	NF-kappa B (NF-kB)IBA 09/2010
1	p38 Mitogen-Activated Protein KinasesIBA 09/2010
1	HydrogenIBA 08/2010
1	Cytotoxins (Cytolysins)IBA 08/2010
1	hydroxide ionIBA 08/2010
1	Histones (Histone)IBA 08/2010
1	PiperazineIBA 08/2010
1	AminesIBA 08/2010

Therapy/Procedure

2	Oral Administration 11/2017 - 07/2011
1	Chemoprevention 01/2022
1	Therapeutics 01/2021
1	Drug Therapy (Chemotherapy) 01/2019
1	Skin Care 01/2018
1	Castration 01/2015